Brivaracetam Tablet, Film Coated
Product Images NDC 73473-908

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 73473-908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solaris�pharma�corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Brivaracetam 01)

Chemical structure of brivaracetam, a human prescription drug. The diagram shows the molecular arrangement including a pyrrolidine ring with attached functional groups representing the active ingredient of the tablet dosage form.*

FDA Label Image

Figure 1 (Brivaracetam 02)

A bar chart comparing the proportion of patients (percentage) experiencing various levels of reduction in seizure frequency from baseline across four groups: placebo and brivaracetam doses of 50 mg/day, 100 mg/day, and 200 mg/day. The x-axis categorizes reduction percentages (Worse, 0 to <25, 25 to <50, 50 to <75, 75 to 100), and the y-axis shows the proportion of patients in each category.*

FDA Label Image

Undefined (Brivaracetam 03)

Label for brivaracetam 10 mg film-coated tablets featuring the product name and strength prominently. The label states the tablets are prescription only (Rx only) and come in a bottle of 60 tablets. It notes storage instructions, distributor Solaris Pharma Corporation (Somerset, NJ), and manufacturer Sunshine Lake Pharma Co., Ltd. (Guangdong Province, China). Contains a barcode and medication guide dispensing instructions for pharmacists.*

FDA Label Image

Undefined (Brivaracetam 04)

Label for Brivaracetam 25 mg film-coated tablets, an oral prescription drug. The label includes storage instructions, distributor Solaris Pharma Corporation, and manufacturer Sunshine Lake Pharma Co., Ltd. The package contains 60 tablets. There is a barcode and the label revision date is 09/2025.*

FDA Label Image

Undefined (Brivaracetam 05)

Label for Brivaracetam 50 mg film-coated tablets, an oral prescription drug distributed by Solaris Pharma Corporation and manufactured by Sunshine Lake Pharma Co., Ltd. The label includes storage instructions, a barcode, and states the package contains 60 tablets. The label cautions to dispense an accompanying medication guide to patients and notes the prescription-only status.*

FDA Label Image

Undefined (Brivaracetam 06)

Brivaracetam 75 mg film-coated tablets label showing medication name, strength, and quantity of 60 tablets. Distributed by Solaris Pharma Corporation and manufactured by Sunshine Lake Pharma Co., Ltd. Storage instructions are noted, and the label includes a barcode and a prescription-only designation.*

FDA Label Image

Undefined (Brivaracetam 07)

Label for Brivaracetam 100 mg film-coated tablets, an oral prescription drug. The label shows the product name, strength, and quantity of 60 tablets. It includes storage instructions and distributor information for Solaris Pharma Corporation, with manufacturing by Sunshine Lake Pharma Co., Ltd. A barcode and revision date of 09/2025 are also visible.*

FDA Label Image

Logo0001-01-2 (Logo0001 01 2)

FDA Label Image

Logo3 (Logo0001 01 3)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.